20 May 2013
Keywords: baxter, market, halozyme, rhuph20, therapeutics, signed, exclusive
Article | 23 August 2004
Halozyme Therapeutics has signed an exclusive deal with fellow US firmBaxter Healthcare under which the latter will market, distribute and
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 August 2004
30 August 2004
16 August 2004
© 2013 thepharmaletter.com